Skip to main content
Erschienen in: Current Treatment Options in Neurology 11/2017

01.11.2017 | Neurologic Ophthalmology and Otology (RK Shin and DR Gold, Section Editors)

Current Treatment Options: Vestibular Migraine

verfasst von: Clinton G. Lauritsen, DO, Michael J. Marmura, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Opinion statement

Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular symptoms. Some present with attacks before or during typical migraine, but many others have fluctuating or daily symptoms. While the symptoms and pathogenesis of vestibular migraine may have elements of both central and peripheral disorders, hearing loss should be absent. VM typically worsens with activity and head movements in general, and encompasses symptoms of vertigo, disequilibrium, or imbalance. While it is possible to confuse other disorders such as Meniere’s disease with migraine, it is worth making the diagnosis of vestibular migraine on clinical grounds after ruling out other possible causes. For acute attack treatment, migraine-specific medications such as triptans may be effective. In patients with frequent or disabling attacks, preventive treatment is essential. Vestibular rehabilitation may be helpful as well as medications used for migraine prevention such as including propranolol, venlafaxine, topiramate, and amitriptyline. For refractory patients, use of acetazolamide or lamotrigine may be reasonable.
Literatur
1.
Zurück zum Zitat Stovner L, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.CrossRefPubMed Stovner L, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.CrossRefPubMed
2.
Zurück zum Zitat Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.CrossRefPubMed Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.CrossRefPubMed
3.
Zurück zum Zitat • Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35. This article is one of few population studies assessing prevalence of migrainous vertigo.CrossRefPubMed • Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35. This article is one of few population studies assessing prevalence of migrainous vertigo.CrossRefPubMed
4.
Zurück zum Zitat •• Neuhauser HK, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33. This article is the largest population study assessing prevalence of migrainous vertigo.CrossRefPubMed •• Neuhauser HK, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33. This article is the largest population study assessing prevalence of migrainous vertigo.CrossRefPubMed
6.
Zurück zum Zitat Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the international classification of vestibular disorders. Neurol Clin. 2015;33(3):541–50. viiCrossRefPubMed Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the international classification of vestibular disorders. Neurol Clin. 2015;33(3):541–50. viiCrossRefPubMed
7.
Zurück zum Zitat Cal R, Bahmad F Jr. Migraine associated with auditory-vestibular dysfunction. Braz J Otorhinolaryngol. 2008;74(4):606–12.CrossRefPubMed Cal R, Bahmad F Jr. Migraine associated with auditory-vestibular dysfunction. Braz J Otorhinolaryngol. 2008;74(4):606–12.CrossRefPubMed
8.
9.
Zurück zum Zitat •• Headache Classification Committee of the International Headache, S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This publication defines the current standard for diagnosis of vestibular migraine.CrossRef •• Headache Classification Committee of the International Headache, S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This publication defines the current standard for diagnosis of vestibular migraine.CrossRef
10.
Zurück zum Zitat •• Neuhauser H, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41. This article features population data analyzing features of migrainous vertigo.CrossRefPubMed •• Neuhauser H, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41. This article features population data analyzing features of migrainous vertigo.CrossRefPubMed
11.
Zurück zum Zitat Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.CrossRefPubMed Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.CrossRefPubMed
12.
Zurück zum Zitat Chen J, et al. Clinical characteristics of 100 vestibular migraine cases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(5):399–401.PubMed Chen J, et al. Clinical characteristics of 100 vestibular migraine cases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(5):399–401.PubMed
13.
Zurück zum Zitat Van Ombergen A, et al. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133–8.PubMed Van Ombergen A, et al. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133–8.PubMed
14.
Zurück zum Zitat Langhagen T, et al. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Front Neurol. 2014;5:292.PubMed Langhagen T, et al. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Front Neurol. 2014;5:292.PubMed
15.
Zurück zum Zitat Qiu F, et al. An analysis of clinical features of 226 vestibular migraine patients. Zhonghua Nei Ke Za Zhi. 2014;53(12):961–3.PubMed Qiu F, et al. An analysis of clinical features of 226 vestibular migraine patients. Zhonghua Nei Ke Za Zhi. 2014;53(12):961–3.PubMed
16.
Zurück zum Zitat Goto F, Tsutsumi T, Ogawa K. The clinical features of migraine-associated vertigo. Nihon Jibiinkoka Gakkai Kaiho. 2013;116(8):953–9.CrossRefPubMed Goto F, Tsutsumi T, Ogawa K. The clinical features of migraine-associated vertigo. Nihon Jibiinkoka Gakkai Kaiho. 2013;116(8):953–9.CrossRefPubMed
17.
Zurück zum Zitat Martinez E, et al. Clinical characteristics of vestibular migraine: considerations in a series of 41 patients. Rev Neurol. 2017;64(1):1–6.PubMed Martinez E, et al. Clinical characteristics of vestibular migraine: considerations in a series of 41 patients. Rev Neurol. 2017;64(1):1–6.PubMed
18.
Zurück zum Zitat Neff BA, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.CrossRefPubMed Neff BA, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.CrossRefPubMed
19.
Zurück zum Zitat Kattah JC, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.CrossRefPubMedPubMedCentral Kattah JC, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.CrossRefPubMedPubMedCentral
20.
21.
Zurück zum Zitat Seltzer S, McCabe BF. Perilymph fistula: the Iowa experience. Laryngoscope. 1986;96(1):37–49.CrossRefPubMed Seltzer S, McCabe BF. Perilymph fistula: the Iowa experience. Laryngoscope. 1986;96(1):37–49.CrossRefPubMed
22.
Zurück zum Zitat Minor LB, et al. Symptoms and signs in superior canal dehiscence syndrome. Ann N Y Acad Sci. 2001;942:259–73.CrossRefPubMed Minor LB, et al. Symptoms and signs in superior canal dehiscence syndrome. Ann N Y Acad Sci. 2001;942:259–73.CrossRefPubMed
23.
Zurück zum Zitat Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9-10PubMed Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9-10PubMed
24.
Zurück zum Zitat Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand. 1995;91(1):43–8.CrossRefPubMed Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand. 1995;91(1):43–8.CrossRefPubMed
25.
Zurück zum Zitat Bulsara KR, Velez DA, Villavicencio A. Rotational vertebral artery insufficiency resulting from cervical spondylosis: case report and review of the literature. Surg Neurol. 2006;65(6):625–7.CrossRefPubMed Bulsara KR, Velez DA, Villavicencio A. Rotational vertebral artery insufficiency resulting from cervical spondylosis: case report and review of the literature. Surg Neurol. 2006;65(6):625–7.CrossRefPubMed
26.
Zurück zum Zitat Cass SP, et al. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106(3):182–9.CrossRefPubMed Cass SP, et al. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106(3):182–9.CrossRefPubMed
27.
Zurück zum Zitat Vongvaivanich K, et al. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35(10):894–911.CrossRefPubMed Vongvaivanich K, et al. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35(10):894–911.CrossRefPubMed
28.
Zurück zum Zitat • Sohn JH. Recent advances in the understanding of vestibular migraine. Behav Neurol. 2016;2016:1801845. This article features recent evidence for pathophysiological mechanisms in vestibular migraine.CrossRefPubMedPubMedCentral • Sohn JH. Recent advances in the understanding of vestibular migraine. Behav Neurol. 2016;2016:1801845. This article features recent evidence for pathophysiological mechanisms in vestibular migraine.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15.CrossRefPubMed Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15.CrossRefPubMed
30.
Zurück zum Zitat Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379–94.CrossRefPubMedPubMedCentral Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379–94.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Vass Z, et al. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84(2):559–67.CrossRefPubMed Vass Z, et al. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84(2):559–67.CrossRefPubMed
32.
Zurück zum Zitat von Brevern M, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74. von Brevern M, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74.
35.
Zurück zum Zitat Marano E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325–31.CrossRefPubMed Marano E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325–31.CrossRefPubMed
36.
Zurück zum Zitat Shin JH, et al. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.CrossRefPubMed Shin JH, et al. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.CrossRefPubMed
37.
Zurück zum Zitat Russo A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.CrossRefPubMed Russo A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.CrossRefPubMed
38.
39.
Zurück zum Zitat •• Cassano D, Pizza V, Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16(Suppl 1):A114. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMedPubMedCentral •• Cassano D, Pizza V, Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16(Suppl 1):A114. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat •• Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–6. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed •• Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–6. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
41.
Zurück zum Zitat •• Neuhauser H, et al. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMed •• Neuhauser H, et al. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMed
42.
Zurück zum Zitat Celebisoy N, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–51.CrossRefPubMed Celebisoy N, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–51.CrossRefPubMed
43.
Zurück zum Zitat • Salmito MC, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404-10. This article is one of few studies for the preventive treatment of vestibular migraine. • Salmito MC, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404-10. This article is one of few studies for the preventive treatment of vestibular migraine.
44.
Zurück zum Zitat •• Taghdiri F, et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Spring. 2014;3:231. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRef •• Taghdiri F, et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Spring. 2014;3:231. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRef
45.
Zurück zum Zitat •• Teggi R, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–73. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed •• Teggi R, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–73. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed
46.
Zurück zum Zitat Teive HA, et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord. 2004;10(4):243–5.CrossRefPubMed Teive HA, et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord. 2004;10(4):243–5.CrossRefPubMed
47.
Zurück zum Zitat • Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–8. This article is one of few studies for the preventive treatment of vestibular migraine. • Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–8. This article is one of few studies for the preventive treatment of vestibular migraine.
48.
Zurück zum Zitat • Waterston J. Chronic migrainous vertigo. J Clin Neurosci. 2004;11(4):384–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed • Waterston J. Chronic migrainous vertigo. J Clin Neurosci. 2004;11(4):384–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
49.
Zurück zum Zitat Morganti LO, et al. Vestibular migraine: clinical and epidemiological aspects. Braz J Otorhinolaryngol. 2016;82(4):397–402.CrossRefPubMed Morganti LO, et al. Vestibular migraine: clinical and epidemiological aspects. Braz J Otorhinolaryngol. 2016;82(4):397–402.CrossRefPubMed
50.
Zurück zum Zitat •• Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;12(1):81–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed •• Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;12(1):81–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
51.
Zurück zum Zitat •• Gode S, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed •• Gode S, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
52.
Zurück zum Zitat • Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005;1039:517–20. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed • Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005;1039:517–20. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
53.
Zurück zum Zitat • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18(3):350–4. This article is one of few studies for acute treament of vestibular migraine.PubMed • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18(3):350–4. This article is one of few studies for acute treament of vestibular migraine.PubMed
54.
Zurück zum Zitat Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89. Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89.
55.
Zurück zum Zitat •• Lepcha A, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed •• Lepcha A, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed
56.
Zurück zum Zitat Brandes JL, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.CrossRefPubMed Brandes JL, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.CrossRefPubMed
57.
Zurück zum Zitat Linde M, et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610. Linde M, et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610.
59.
Zurück zum Zitat Dixon AK, et al. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung. 1977;27(10):1968–79.PubMed Dixon AK, et al. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung. 1977;27(10):1968–79.PubMed
60.
Zurück zum Zitat Vitkovic J, et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.CrossRefPubMed Vitkovic J, et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.CrossRefPubMed
64.
Zurück zum Zitat Radtke A, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.CrossRefPubMed Radtke A, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.CrossRefPubMed
65.
Zurück zum Zitat Lee JW, et al. Clinical manifestation and prognosis of vestibular migraine according to the vestibular function test results. Korean J Audiol. 2013;17(1):18–22.CrossRefPubMedPubMedCentral Lee JW, et al. Clinical manifestation and prognosis of vestibular migraine according to the vestibular function test results. Korean J Audiol. 2013;17(1):18–22.CrossRefPubMedPubMedCentral
Metadaten
Titel
Current Treatment Options: Vestibular Migraine
verfasst von
Clinton G. Lauritsen, DO
Michael J. Marmura, MD
Publikationsdatum
01.11.2017
Verlag
Springer US
Erschienen in
Current Treatment Options in Neurology / Ausgabe 11/2017
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-017-0476-z

Weitere Artikel der Ausgabe 11/2017

Current Treatment Options in Neurology 11/2017 Zur Ausgabe

Critical Care Neurology (K Sheth, Section Editor)

Resumption of Anticoagulation After Intracranial Hemorrhage

Neurologic Ophthalmology and Otology (RK Shin and DR Gold, Section Editors)

Treatment of Blepharospasm/Hemifacial Spasm

Neuromuscular Disorders (C Fournier, Section Editor)

Treatment Opportunities in Patients With Metabolic Myopathies

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.